Masimo (MASI) Capital Expenditures Growth (1y) (2011 - 2026)
Masimo (MASI) Capital Expenditures Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.48 Bn | 176.19 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 129.11 Bn | 126.23 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 68.68 Bn | 67.22 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn | 15.89% |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn | -11.95% |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn | 106.98% |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | -47.73% |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | 197.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 197.73% |
| Jan 3, 2026 | -387.10% |
| Sep 27, 2025 | -61.69% |
| Jun 28, 2025 | 437.50% |
| Mar 29, 2025 | -262.96% |
| Dec 28, 2024 | 116.76% |
| Sep 28, 2024 | 77.01% |
| Jun 29, 2024 | -114.75% |
| Mar 30, 2024 | 0.00% |
| Dec 30, 2023 | -320.24% |
| Sep 30, 2023 | 45.00% |
| Jul 1, 2023 | -27.67% |
| Dec 31, 2022 | 127.99% |
| Apr 3, 2021 | -75.94% |
| Sep 26, 2020 | 226.07% |
| Jun 27, 2020 | -190.59% |
| Mar 28, 2020 | 431.44% |
| Dec 28, 2019 | -96.73% |
| Sep 28, 2019 | -1,747.09% |
| Jun 29, 2019 | 300.64% |